Coya Therapeutics (COYA) reported third-quarter 2026 collaboration revenue of $234,134 and a net loss of $10.6 million, or $0.45 per basic and diluted share. The company had $35.8 million in cash and cash equivalents as of September 30, 2026.
Coya completed enrollment in its Phase 2/3 ALSTARS trial of COYA 302 for amyotrophic lateral sclerosis, enrolling 137 participants. The company expects topline data from the trial’s 24-week double-blind treatment phase in early second-quarter 2027.
- Research and development expense was $8.6 million, compared with $2.9 million a year earlier.
- Collaboration revenue declined from $3.6 million in the prior-year quarter.
- Coya plans an open-label extension for ALSTARS participants completing the 48-week study period.
- The company expects to announce frontotemporal dementia biomarker data in the first quarter of 2027.
$COYA Hedge Fund Activity
We have seen 16 institutional investors add shares of $COYA stock to their portfolio, and 23 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PROSIGHT MANAGEMENT, LP removed 250,360 shares (-59.6%) from their portfolio in Q2 2026, for an estimated $1,464,606
- RENAISSANCE TECHNOLOGIES LLC added 89,022 shares (+85.6%) to their portfolio in Q2 2026, for an estimated $520,778
- ROYAL BANK OF CANADA added 80,022 shares (+597.5%) to their portfolio in Q2 2026, for an estimated $468,128
- 683 CAPITAL MANAGEMENT, LLC removed 70,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $409,500
- JONES FINANCIAL COMPANIES LLLP added 65,950 shares (+146.7%) to their portfolio in Q2 2026, for an estimated $385,807
- CM MANAGEMENT, LLC added 50,000 shares (+14.3%) to their portfolio in Q2 2026, for an estimated $292,500
- POINT72 ASSET MANAGEMENT, L.P. removed 37,681 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $220,433
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.